News | November 12, 2021
Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Acute therapies continue to report strong growth compared to chronic ones.
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
Subscribe To Our Newsletter & Stay Updated
